Annual Cash & Cash Equivalents
$50.52 M
-$34.19 M-40.36%
December 31, 2022
Summary
- As of February 10, 2025, ICPT annual cash & cash equivalents is $50.52 million, with the most recent change of -$34.19 million (-40.36%) on December 31, 2022.
- During the last 3 years, ICPT annual cash & cash equivalents has fallen by -$19.54 million (-27.89%).
Performance
ICPT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$102.74 M
-$33.49 M-24.59%
September 30, 2023
Summary
- As of February 10, 2025, ICPT quarterly cash and cash equivalents is $102.74 million, with the most recent change of -$33.49 million (-24.59%) on September 30, 2023.
- Over the past year, ICPT quarterly cash and cash equivalents has dropped by -$10.46 million (-9.24%).
Performance
ICPT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ICPT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.4% | -9.2% |
| 3 y3 years | -27.9% | +126.7% |
| 5 y5 years | -27.9% | +73.0% |
ICPT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.4% | at low | -24.6% | -53.0% |
| 5 y | 5-year | -40.4% | at low | -29.4% | -59.7% |
| alltime | all time | -40.4% | -73.5% | -29.4% | -89.1% |
Intercept Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $102.74 M(-24.6%) |
| Jun 2023 | - | $136.23 M(+121.9%) |
| Mar 2023 | - | $61.40 M(+21.6%) |
| Dec 2022 | $50.52 M(-40.4%) | $50.52 M(-55.4%) |
| Sep 2022 | - | $113.19 M(+95.1%) |
| Jun 2022 | - | $58.02 M(+20.1%) |
| Mar 2022 | - | $48.32 M(-43.0%) |
| Dec 2021 | $84.71 M(+45.7%) | $84.71 M(+24.0%) |
| Sep 2021 | - | $68.33 M(-53.1%) |
| Jun 2021 | - | $145.62 M(+56.7%) |
| Mar 2021 | - | $92.95 M(+59.8%) |
| Dec 2020 | $58.15 M(-17.0%) | $58.15 M(+28.3%) |
| Sep 2020 | - | $45.31 M(-10.8%) |
| Jun 2020 | - | $50.78 M(+22.6%) |
| Mar 2020 | - | $41.41 M(-40.9%) |
| Dec 2019 | $70.06 M(+62.0%) | $70.06 M(+10.5%) |
| Sep 2019 | - | $63.38 M(-32.2%) |
| Jun 2019 | - | $93.50 M(+70.9%) |
| Mar 2019 | - | $54.72 M(+26.5%) |
| Dec 2018 | $43.25 M(-38.2%) | $43.25 M(-27.2%) |
| Sep 2018 | - | $59.38 M(-23.6%) |
| Jun 2018 | - | $77.72 M(+59.0%) |
| Mar 2018 | - | $48.87 M(-30.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $70.01 M(+60.3%) | $70.01 M(-41.8%) |
| Sep 2017 | - | $120.24 M(+93.8%) |
| Jun 2017 | - | $62.03 M(-7.3%) |
| Mar 2017 | - | $66.95 M(+53.3%) |
| Dec 2016 | $43.67 M(+33.4%) | $43.67 M(-58.5%) |
| Sep 2016 | - | $105.22 M(+103.5%) |
| Jun 2016 | - | $51.70 M(+5.1%) |
| Mar 2016 | - | $49.20 M(+50.3%) |
| Dec 2015 | $32.74 M(+63.5%) | $32.74 M(-54.7%) |
| Sep 2015 | - | $72.35 M(-18.0%) |
| Jun 2015 | - | $88.26 M(-15.4%) |
| Mar 2015 | - | $104.37 M(+421.2%) |
| Dec 2014 | $20.02 M(+49.8%) | $20.02 M(+10.9%) |
| Sep 2014 | - | $18.06 M(-59.8%) |
| Jun 2014 | - | $44.96 M(+301.1%) |
| Mar 2014 | - | $11.21 M(-16.1%) |
| Dec 2013 | $13.36 M(-70.6%) | $13.36 M(-60.1%) |
| Sep 2013 | - | $33.49 M(-35.8%) |
| Jun 2013 | - | $52.14 M(+64.4%) |
| Mar 2013 | - | $31.71 M(-30.3%) |
| Dec 2012 | $45.51 M(+157.0%) | $45.51 M(+26.5%) |
| Sep 2012 | - | $35.97 M(-9.5%) |
| Jun 2012 | - | $39.75 M(+124.5%) |
| Dec 2011 | $17.71 M | $17.71 M |
FAQ
- What is Intercept Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Intercept Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Intercept Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ICPT is $50.52 M
What is the all time high annual cash & cash equivalents for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual cash & cash equivalents is $84.71 M
What is Intercept Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ICPT annual cash & cash equivalents has changed by -$34.19 M (-40.36%)
What is Intercept Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ICPT is $102.74 M
What is the all time high quarterly cash and cash equivalents for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly cash and cash equivalents is $145.62 M
What is Intercept Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ICPT quarterly cash and cash equivalents has changed by -$10.46 M (-9.24%)